Thomas Muething

Earlier this month, Anderson told me she submitted a co-authored op-ed to The New York Times warning that many transgender healthcare providers were treating kids recklessly. The Times passed, explaining it was “outside our coverage priorities right now.”

Over the past few weeks, I have spoken at length to both women about the current direction of their field and where they feel it has gone wrong. On some issues, including their stance on puberty blockers, they raised concerns that appear to question the current health guidelines set by WPATH — which Bowers is slated to lead starting in 2022.

WPATH, for instance, recommends that for many gender dysphoric and gender non-conforming kids, hormonal puberty suppression begin at the early stages of puberty. WPATH has also insisted since 2012 that puberty blockers are “fully reversible interventions.”

When I asked Anderson if she believes that psychological effects of puberty blockers are reversible, she said: “I’m not sure.” When asked whether children in the early stages of puberty should be put on blockers, Bowers said: “I’m not a fan.”

[emphasis added]

Source

In fact, according to this article, the risk of suicide and NSSI goes up following gender-affirming surgery.